Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Treasury Shares (2017 - 2025)

Marimed (MRMD) has disclosed Treasury Shares for 2 consecutive years, with $545000.0 as the latest value for Q2 2018.

  • On a quarterly basis, Treasury Shares changed N/A to $545000.0 in Q2 2018 year-over-year; TTM through Jun 2018 was $545000.0, a N/A change, with the full-year FY2017 number at $45000.0, changed N/A from a year prior.
  • Treasury Shares was $8.5 million for Q3 2025 at Marimed, down from $10.6 million in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $545000.0 in Q2 2018 to a low of -$45000.0 in Q3 2017.
  • A 5-year average of $5.3 million and a median of $5.6 million in 2023 define the central range for Treasury Shares.
  • Peak YoY movement for Treasury Shares: crashed 80.33% in 2021, then skyrocketed 1904.63% in 2022.
  • Marimed's Treasury Shares stood at $45000.0 in 2017, then skyrocketed by 1111.11% to $545000.0 in 2018.
  • Per Business Quant, the three most recent readings for MRMD's Treasury Shares are $8.5 million (Q3 2025), $10.6 million (Q2 2025), and $10.6 million (Q1 2025).